AI vs. doctors: the race to spot diabetic eye damage
NCT ID NCT07222293
Summary
This study is testing an artificial intelligence (AI) software called DRISTi to see if it can accurately screen for diabetic retinopathy, a common eye complication of diabetes. It will enroll 900 adults with diabetes to have their eye images analyzed by the AI and by human experts, comparing the results. The goal is to prove the AI tool is effective for automated, early detection of this vision-threatening condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY (DR) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
New Century Ophthalmology - Oxford
RECRUITINGOxford, North Carolina, 27565, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
New Century Ophthalmology - Raleigh
RECRUITINGRaleigh, North Carolina, 27617, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.